{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T06:25:32Z","timestamp":1788330332051,"version":"build-2803163510"},"reference-count":35,"publisher":"Impact Journals, LLC","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,5,29]]},"DOI":"10.18632\/aging.103210","type":"journal-article","created":{"date-parts":[[2020,5,29]],"date-time":"2020-05-29T16:48:21Z","timestamp":1590770901000},"page":"9354-9364","source":"Crossref","is-referenced-by-count":27,"title":["Efficacies of different ovarian hyperstimulation protocols in poor ovarian responders classified by the POSEIDON criteria"],"prefix":"10.18632","volume":"12","author":[{"given":"Fei","family":"Li","sequence":"first","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"},{"name":"Center for Reproductive Medicine, The First People\u2019s Hospital of Shangqiu, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Ye","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Kong","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linli","family":"Hu","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HaiXia","family":"Jin","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchun","family":"Su","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gang","family":"Li","sequence":"additional","affiliation":[{"name":"Center for Reproductive Medicine, The First Affiliated Hospital of Zhengzhou University, and Henan Province Key Laboratory of Reproduction and Genetics, Henan, People\u2019s Republic of China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,5,29]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1186\/s12958-018-0343-0","article-title":"Pretreatment with coenzyme Q10 improves ovarian response and embryo quality in low-prognosis young women with decreased ovarian reserve: a randomized controlled trial.","volume":"1","author":"Wang","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"2","doi-asserted-by":"publisher","first-page":"581","DOI":"10.1016\/j.rbmo.2015.03.002","article-title":"How to define, diagnose and treat poor responders? Responses from a worldwide survey of IVF clinics.","volume":"3","author":"Shoham","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"3","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1093\/humupd\/dmw001","article-title":"Trends in \u2018poor responder\u2019 research: lessons learned from RCTs in assisted conception.","volume":"2","author":"Bhattacharya","year":"2016","journal-title":"Hum Reprod Update"},{"key":"4","doi-asserted-by":"publisher","first-page":"1616","DOI":"10.1093\/humrep\/der092","article-title":"ESHRE consensus on the definition of \u2018poor response\u2019 to ovarian stimulation for in vitro fertilization: the Bologna criteria.","volume":"2","author":"Gianaroli","year":"2011","journal-title":"Hum Reprod"},{"key":"5","doi-asserted-by":"publisher","first-page":"1835","DOI":"10.1093\/humrep\/deu135","article-title":"Implementing the ESHRE \u2018poor responder\u2019 criteria in research studies: methodological implications.","volume":"2","author":"Papathanasiou","year":"2014","journal-title":"Hum Reprod"},{"key":"6","doi-asserted-by":"publisher","first-page":"1058","DOI":"10.1016\/j.fertnstert.2011.09.048","article-title":"A systematic review of randomized trials for the treatment of poor ovarian responders: is there any light at the end of the tunnel?","volume":"9","author":"Devroey","year":"2011","journal-title":"Fertil Steril"},{"key":"7","doi-asserted-by":"publisher","first-page":"1452","DOI":"10.1016\/j.fertnstert.2016.02.005","article-title":"A new more detailed stratification of low responders to ovarian stimulation: from a poor ovarian response to a low prognosis concept.","volume":"10","author":"Humaidan","year":"2016","journal-title":"Fertil Steril"},{"key":"8","doi-asserted-by":"publisher","first-page":"246","DOI":"10.3389\/fendo.2019.00246","article-title":"Understanding Follicular Output Rate (FORT) and its Implications for POSEIDON Criteria.","volume":"1","author":"Labrosse","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"9","doi-asserted-by":"publisher","first-page":"370","DOI":"10.1093\/humrep\/dev316","article-title":"Conventional ovarian stimulation and single embryo transfer for IVF\/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?","volume":"3","author":"Polyzos","year":"2016","journal-title":"Hum Reprod"},{"key":"10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.3389\/fendo.2019.00458","article-title":"Androgens Profile in Blood Serum and Follicular Fluid of Women With Poor Ovarian Response During Controlled Ovarian Stimulation Reveals Differences Amongst POSEIDON Stratification Groups: A Pilot Study.","volume":"1","author":"Godoy","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"11","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3389\/fendo.2019.00614","article-title":"Management Strategies for POSEIDON Groups 3 and 4.","volume":"1","author":"Humaidan","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"12","doi-asserted-by":"publisher","first-page":"281","DOI":"10.3389\/fendo.2019.00281","article-title":"Ovarian Reserve Markers to Identify Poor Responders in the Context of Poseidon Classification.","volume":"1","author":"La Marca","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"13","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/j.fertnstert.2014.03.030","article-title":"Does prolonged pituitary down-regulation with gonadotropin-releasing hormone agonist improve the live-birth rate in in vitro fertilization treatment?","volume":"10","author":"Ma","year":"2014","journal-title":"Fertil Steril"},{"key":"14","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1007\/s11596-019-2056-9","article-title":"Influence of Different Gonadotropin-releasing Hormone Agonist Administration Methods on Pregnancy Outcomes of Patients Undergoing In-vitro Fertilization-embryo Transfer.","volume":"3","author":"Jin","year":"2019","journal-title":"Curr Med Sci"},{"key":"15","doi-asserted-by":"publisher","first-page":"e0175985","DOI":"10.1371\/journal.pone.0175985","article-title":"Comparisons of GnRH antagonist protocol versus GnRH agonist long protocol in patients with normal ovarian reserve: A systematic review and meta-analysis.","volume":"1","author":"Zhou","year":"2017","journal-title":"PLoS One"},{"key":"16","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.fertnstert.2010.06.068","article-title":"Gonadotropin-releasing hormone agonists versus antagonists for controlled ovarian hyperstimulation in oocyte donors: a systematic review and meta-analysis.","volume":"9","author":"Coomarasamy","year":"2011","journal-title":"Fertil Steril"},{"key":"17","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.rbmo.2014.05.007","article-title":"GnRH agonist and GnRH antagonist protocols: comparison of outcomes among good-prognosis patients using national surveillance data.","volume":"2","author":"Macaluso","year":"2014","journal-title":"Reprod Biomed Online"},{"key":"18","doi-asserted-by":"publisher","first-page":"2321","DOI":"10.1093\/humrep\/dev198","article-title":"Live birth rates after modified natural cycle compared with high-dose FSH stimulation using GnRH antagonists in poor responders.","volume":"3","author":"Kolibianakis","year":"2015","journal-title":"Hum Reprod"},{"key":"19","doi-asserted-by":"publisher","first-page":"CD001750","DOI":"10.1002\/14651858.CD001750.pub4","article-title":"Gonadotrophin-releasing hormone antagonists for assisted reproductive technology.","volume":"4","author":"Broekmans","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"20","first-page":"209","article-title":"Poor responders in IVF\u2014is there any evidence-based treatment for them?","volume":"3","author":"Wielgos","year":"2015","journal-title":"Neuro Endocrinol Lett"},{"key":"21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.3389\/fendo.2018.00767","article-title":"Flexible Low-Dose GnRH Antagonist Protocol Is Effective in Patients With Sufficient Ovarian Reserve in IVF.","volume":"9","author":"Xu","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"22","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.ejogrb.2012.09.008","article-title":"GnRH antagonist versus long GnRH agonist protocol in poor IVF responders: a randomized clinical trial.","volume":"16","author":"Prapas","year":"2013","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"23","doi-asserted-by":"publisher","first-page":"39912","DOI":"10.1038\/srep39912","article-title":"Increased Uterine NK cell numbers and perforin expression during the implantation phase in IVF Cycles with GnRH Antagonist Protocol.","volume":"7","author":"Zhang","year":"2017","journal-title":"Sci Rep"},{"key":"24","doi-asserted-by":"publisher","first-page":"1294","DOI":"10.1016\/j.fertnstert.2007.10.022","article-title":"GnRH agonist versus GnRH antagonist in ovarian stimulation: the role of endometrial receptivity.","volume":"9","author":"Nahum","year":"2008","journal-title":"Fertil Steril"},{"key":"25","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1095\/biolreprod.109.081299","article-title":"Controlled ovarian hyperstimulation for in vitro fertilization alters endometrial receptivity in humans: protocol effects.","volume":"8","author":"Hamamah","year":"2010","journal-title":"Biol Reprod"},{"key":"26","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.yjmcc.2014.03.011","article-title":"Mitochondrial reactive oxygen species production and elimination.","volume":"7","author":"Maack","year":"2014","journal-title":"J Mol Cell Cardiol"},{"key":"27","doi-asserted-by":"publisher","DOI":"10.1080\/14647273.2019.1685687","article-title":"Are early follicular phase serum progranulin levels predictive of the response to ovarian stimulation in IVF cycles?","volume":"1","author":"Tokmak","year":"2019","journal-title":"Hum Fertil (Camb)"},{"key":"28","doi-asserted-by":"publisher","first-page":"814","DOI":"10.3389\/fendo.2019.00814","article-title":"The POSEIDON Criteria and Its Measure of Success Through the Eyes of Clinicians and Embryologists.","volume":"1","author":"\u00d6zbek","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"29","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1093\/humupd\/dmx017","article-title":"GnRH antagonist versus long agonist protocols in IVF: a systematic review and meta-analysis accounting for patient type.","volume":"2","author":"van Wely","year":"2017","journal-title":"Hum Reprod Update"},{"key":"30","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1016\/j.fertnstert.2018.01.020","article-title":"Resveratrol improves in vitro maturation of oocytes in aged mice and humans.","volume":"10","author":"Liu","year":"2018","journal-title":"Fertil Steril"},{"key":"31","doi-asserted-by":"publisher","first-page":"e0207081","DOI":"10.1371\/journal.pone.0207081","article-title":"GnRH agonist long protocol versus GnRH antagonist protocol for various aged patients with diminished ovarian reserve: A retrospective study.","volume":"1","author":"Lee","year":"2018","journal-title":"PLoS One"},{"key":"32","doi-asserted-by":"publisher","first-page":"2373","DOI":"10.1093\/humrep\/dei086","article-title":"GnRH antagonists in ovarian stimulation: a treatment regimen of clinicians\u2019 second choice? Data from the German national IVF registry.","volume":"2","author":"Diedrich","year":"2005","journal-title":"Hum Reprod"},{"key":"33","doi-asserted-by":"publisher","first-page":"1555","DOI":"10.1111\/1471-0528.15942","article-title":"Preimplantation genetic screening should be used in all in vitro fertilisation cycles in women over the age of 35 years: AGAINST: Pre-implantation genetic screening should not be used in all IVF cycles in women over the age of 35 years.","volume":"12","author":"Ledger","year":"2019","journal-title":"BJOG"},{"key":"34","doi-asserted-by":"publisher","first-page":"3","DOI":"10.23736\/S0031-0808.18.03507-3","article-title":"Estimation of age-dependent decrease in blastocyst euploidy by next generation sequencing: development of a novel prediction model.","volume":"6","author":"Alviggi","year":"2019","journal-title":"Panminerva Med"},{"key":"35","doi-asserted-by":"publisher","first-page":"w14087","DOI":"10.4414\/smw.2015.14087","article-title":"Twenty years' experience with the Swiss data registry for assisted reproductive medicine: outcomes, key trends and recommendations for improved practice.","volume":"14","author":"von Wolff","year":"2015","journal-title":"Swiss Med Wkly"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103210","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T20:24:02Z","timestamp":1599078242000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.103210"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,29]]},"references-count":35,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,5,31]]}},"alternative-id":["103210","32470947"],"URL":"https:\/\/doi.org\/10.18632\/aging.103210","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,29]]}}}